TherapeuticsMD, Inc. — Director's Dealing 2013

Aug 28, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2013-08-26

Reporting Person: Bernick Brian (Director, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-08-26	Common Stock	S	1600000	$1.55	Disposed	7519767	Indirect

Footnotes

F1: Shares owned by BF Investment Enterprises, Ltd., an entity solely owned by Dr. Bernick.